IntroDuctIon
Cardiovascular disease (CVD) currently affects 36.9% of the United States population with an estimated direct medical cost of $272.5 billion annually in 2010 (ref. 1) . When considering indirect costs from lost productivity due to mortality and morbidity, the cost to society exceeds $444 billion annually 1 . Coronary heart disease, MI and heart failure account for a third of the total economic burden of CVD to the United States 1 . The direct medical costs of CVD are projected to double in the next 20 years, with the total cost of CVD exceeding one trillion dollars by 2030 (ref. 1) . The 2011 American Heart Association statistics update revealed that there are 1,172,000 cases of acute coronary syndrome annually in the United States; of these cases, 730,000 are designated as acute MI 2 . Considering the personal and economic impact of CVD and the anticipated increase in prevalence in the next 20 years, the use of a sustainable and reproducible large animal model, as described below, that closely replicates the clinical sequelae of MI is required.
Swine are superior large animal models for studies of acute MI and ischemic cardiomyopathy (ICM) 3 . The blood vessel size and shape are comparable between swine and human vasculature 3, 4 . In particular, the coronary artery anatomy, size, structure and distribution make them suitable for preclinical cardiovascular research 4 . The porcine anatomy allows for occlusion of the left anterior descending coronary artery (LAD), and this is commonly used as a model of human CVD [5] [6] [7] [8] [9] . As with human anatomy, the porcine LAD provides approximately half of the blood supply to the left ventricle (LV), and its occlusion creates an infarction of the anteroapical, lateral and septal walls of the LV that is similar in size and distribution to that occurring in humans with MI as a result of LAD occlusion 3 . This type of ischemia produces considerably more impairment of LV global function than left circumflex artery (LCX) occlusions. The higher level of global impairment leads to markedly different compensatory changes in infarct border zone function compared with LCX occlusions. Therefore, the location of MI is an important predictor of depressed global cardiac function after MI 10 . Although the LCX occlusion technique has its benefits, such as lower procedural mortality, LAD occlusion is the preferred model for preclinical studies, considering that this is where the majority of human MIs occur 11 . Moreover, the pattern of remodeling as a result of the MI closely resembles that occurring in humans 10 . Consequently, the greater change in global cardiac parameters and location of infarction zone produces the most clinically relevant results for translational research.
Given the similarities in human and swine anatomy, many of the same imaging techniques used in humans can be used on swine. Echocardiography and cardiac magnetic resonance imaging (CMR) allow for noninvasive cardiac measurements such as myocardial mass, scar mass, left ventricular volumes, geometric remodeling, scar reduction, contractility, myocardial perfusion and viable myocardial mass regeneration to be quantified. Invasive studies such as pressure-volume loop analysis can give a comprehensive evaluation of cardiovascular performance, including indices of preload, afterload, lusitropy, inotropy and measures of integrated cardiac function 12 . These similarities make the swine model highly appropriate for translational research, as the equipment and procedural techniques used to quantify these variables are analogous to those used in humans.
Experimental MI design
The model of ischemia-reperfusion MI described here is a closedchest approach using clinical cardiac catheterization techniques. We attempted a percutaneous method of intravascular access to further minimize the invasiveness of the procedure, but porcine arteries are prone to vasospams and surgical access was often required after unsuccessful arterial puncture. The common carotid artery is too deep to palpate, thus hindering safe and reliable access percutaneously. In addition, the femoral vasculature is not ideal for percutaneous access, because of its smaller vessel size and the difficulty of palpating the femoral pulse. Surgical dissection of the vasculature
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at either location provides more dependable access with fewer complications. Surgical dissection of the neck further optimizes access, as it provides a direct route to the heart without having to navigate across the aortic arch. The vasculature of the neck has fewer branches than the femoral vasculature and is larger, further easing vascular control and access.
To create a reproducible model of MI, a percutaneous transluminal coronary angioplasty (PTCA) dilation catheter is inflated to occlude all flow distal to the first diagonal branch of the LAD. By maintaining the patency of the first diagonal branch, a portion of the LV continues to receive normal blood perfusion. Having some healthy LV muscle provides well-defined remote and border zones to the infarcted LV for comparative evaluation in preclinical studies. Consequently, this reduces the fatalities during the procedure and also creates fewer complications of congestive heart failure after MI. LAD occlusion is advantageous for research studies, as the infarct and border zones are easily accessible via both percutaneous transcatheter delivery techniques and thoracotomy, thus allowing for direct surgical interventions in study protocols. By using different breeds of swine, the timescale of the model can be varied. Figure 1 shows sample timelines for acute MI studies and chronic ICM studies. Farm pigs, like the Yorkshire, are particularly suited for acute MI studies, whereas the Göttingen (a trademark of Ellegaard) miniature swine are preferred for longterm ICM studies 9 . Yorkshire swine are excellent models for acute studies as they reach size and weights suitable for research within 3 months of birth. In addition, there is greater accessibility and less initial cost than miniature swine. However, the fast initial growth rate limits study length to around 3 months, given the age-dependence of cardiovascular compensatory mechanisms 10 . Göttingen swine are an ideal chronic model as they reach mature weights at around 1 year of age and the growth curve plateaus 13 . In addition, Göttingen swine also see closure of growth lines at 18-22 months, thereby allowing for long-term research without substantial growth.
During the first month after an MI, the swine heart, similarly to the human heart, undergoes drastic left ventricular remodeling.
After 3 months, the geometric and cellular remodeling process has stabilized and allows for chronic studies. Consequently, the acute model is useful for studying interventions to limit or prevent remodeling, whereas the chronic model is more applicable to focusing on the reversal and restoration of cardiac muscle tissue and the geometric configuration of the LV, bearing in mind the particular advantages of Yorkshire or Göttingen swine 9, 14 . Occlusion times of 90 min for Yorkshire swine or 150 min for Göttingen swine provide predictable and reproducible MI of the anteroapical, lateral and septal walls of the LV. After occlusion, the myocardium is fully reperfused to mimic the clinical MI disease model with relevant interventions in humans. Furthermore, reperfusion of the heart after coronary artery occlusion minimizes additional myocardial cell death and decreases swine mortality. Despite reperfusion of the ischemic areas, remodeling of the heart occurs over the next several months and continues to damage the heart and deteriorate cardiac performance 15 . Post-MI parameters, such as scar size, location and ventricular impairment, are easily titrated by varying occlusion time or location in order to vary LV remodeling and suit the needs of the research project. This provides an ideal model for investigation of potential interventions for acute, subacute and chronic studies after MI.
Implications for the swine MI model in cellular and regenerative therapy. It has long been thought that the mammalian heart lacks the capacity for regeneration, but recent breakthroughs in cardiovascular stem cell therapies are starting to decipher the mysteries of activating the dormant intrinsic regenerative capacity 16 . Stem cells are an emerging therapy for heart failure, and research shows many viable options for delivery of biological products to the heart (Boxes 1 and 2; Table 1 ). Whereas intravenous (i.v.) or intracoronary delivery allow for less invasive stem cell infusions, intramyocardial injections have the highest engraftment and retention rates with less systemic organ engraftment [17] [18] [19] . The disadvantage of direct transepicardial injections is the need to surgically expose the heart (Box 1). Concurrent delivery with coronary artery bypass graft, ventricular assist device placement or other open-chest procedures allows treatment with minimal additional surgical risk, but limits patients on the basis of the need for the aforementioned surgeries. Steerable percutaneous catheters allow for minimally invasive transendocardial stem cell injections (TESI; Box 2) to directed areas of interest from within the heart 18, 19 . The swine MI model was crucial to demonstrating that steerable catheters are able to safely deliver cell therapies to target areas of the heart. Swine models also provide important engraftment and safety data for TESI using steerable catheters while demonstrating their enhanced ability to target specific areas in the heart 6, [20] [21] [22] . Additionally, interventional cardiologists used the swine model to acquire the technical proficiencies required before conducting the first TESI for clinical trials.
At present, translational research focusing on regenerative medicine aims to establish the safety and efficacy of cell-based therapy (and other biological strategies), with the goal of offering patients a new therapeutic intervention. Stem cell-based research aims to not only restore cardiac function, but also prevent or reverse the negative effects seen from post-MI remodeling, thereby fulfilling a major unmet medical need. New and exciting stem cell therapies 
Box 1 | Surgical transepicardial injection of stem cells • tIMInG 3-4 h
1. Follow Steps 1-14 of the main PROCEDURE to prepare the animal and obtain CMR measurements. 2. Prepare the angiography table by placing a V-shaped trough tabletop adapter draped with a Bair hugger blanket and sand bags to position the animal properly and maintain euthermia. Place the swine in a dorsal recumbent position and secure it using sand bags. Retract the front hooves and hold them posteriorly to facilitate access to the vasculature of the neck (Fig. 4) . Retract the rear hooves caudolaterally with slight flexion of the hip joint and restrain them in place to facilitate access to the femoral canal.  crItIcal step At a minimum, pulse oximetry and heart rate must be monitored during surgical preparation. Vital parameters such as pulse oximetry, heart rate, blood pressure, temperature and capnography should be monitored throughout the procedure to ensure proper anesthesia depth and swine health.
3. Obtain vascular access to the swine as detailed in Step 17 of the main PROCEDURE. 4. Obtain preinjection pressure-volume measurements, as detailed in Steps 18-23 of the main PROCEDURE. 5. Palpate the left chest to localize the fourth through sixth intercostal spaces. 6. Make a 6-8 cm incision immediately above the fifth rib, beginning ~3 cm lateral to the sternum and extending posteriorly. Transect the latissimus dorsi, external abdominal oblique, serratus ventralis and pectoralis ascendons, carefully ligating the veins and arteries encountered. 7. Once above the fifth rib, advance a mosquito forceps over the fifth rib and through the fourth intercostal space into the left thoracic cavity. Open the mosquito forceps and retract to enlarge the hole. Extend the incision along the intercostal space by using Metzenbaum scissors to create an adequate surgical window.  crItIcal step Care should be taken to protect the delicate lung tissue while entering the thoracic cavity. Pausing mechanical ventilation at peak exhalation can minimize the risk of pulmonary injury. 8. Place a Weitlaner within this incision to retract the ribs and provide a working window to the left thoracic cavity (Fig. 10a) . Swine have small intercostal spaces and may require enlargement of the surgical window by transecting the anterior aspect of the fifth rib. 9. Place a 5-mm port in the 6th intercostal space, and insert a 5-mm endoscope into the left thoracic cavity to improve visualization of the heart and aid in placement of the transepicardial injections. ). 10. Under thoracoscopic guidance, retract the pericardium away from the myocardium and incise the pericardium using Metzenbaum scissors to provide access and visualization of the infarcted and border zones of the heart (Fig. 10b) .  crItIcal step Care should be taken to open the pericardium to avoid injuring the phrenic nerve, which runs along the posterior aspect of the pericardium. Pausing mechanical ventilation at peak exhalation can minimize the risk of pulmonary injury and enhance visualization of the myocardium. 11. Directly visualize the heart by using the endoscope to map and plan the distribution of the product to be injected to the area(s) of interest.  crItIcal step Preoperative review of the previously acquired LGE-CMR scar images (Fig. 3) , left ventriculograms and coronary angiograms obtained during induction of MI will help in mapping the infarct and border zones. Injection volumes should not exceed 0.5 ml per injection site and should be equally distributed throughout the targeted area(s). 12. Insert a curved 27-gauge needle perpendicularly to the epicardium and advance into the myocardium (Fig. 10c,d ). Direct intramyocardial injections into the infarct and border zone, taking care to avoid intracoronary injection. Lack of blood return with slight negative pressure on the syringe will confirm proper placement.  crItIcal step Administer injections slowly and carefully. Watch injection sites for bleeding or product washout after needle withdrawal. Bleeding can be controlled with direct digital pressure if needed. ? trouBlesHootInG 13. Repeat step 12 for each injection. 14. After completion of myocardial injections, check the thoracic cavity for bleeding and control as necessary. 15 . Advance a 12F chest tube through the 5-mm port into the thoracic cavity in a dorsocranial position and connect it to a chest drainage system providing −20 cm of water suction. 16 . Close the minithoracotomy incision site in layers providing a watertight seal. 17. Remove the vascular introducer(s) and repair or ligate the artery as needed. Ligate the vein. 18. Close femoral incision site in layers. 19 . Clean the incision site(s) in a sterile manner; place triple antibiotic ointment over the incision sites. Cover incision sites with sterile nonadherent pads and enclose with waterproof dressings. ? trouBlesHootInG 20. A water seal should exist in the chest drainage system without bubbling, indicating complete evacuation of the pneumothorax. Confirm complete lung re-expansion by fluoroscopy before removing the chest tube.  crItIcal step Do not remove the chest tube if there is ≥10 ml h − 1 drainage or an air leak present, or if the animal has an unstable respiratory status or oxygenation status. Positive pressure ventilations after removing the chest tube can increase the risk of tension pneumothorax. 21 . Place a purse-string suture around the chest tube. On peak inspiration, gently but swiftly remove the chest tube while simultaneously tying the purse-string suture. 22. Clean the chest tube site in a sterile manner; place triple antibiotic ointment over the site and cover incision sites with sterile nonadherent pads and enclose with waterproof dressings. 23. Once the chest tube has been removed, use fluoroscopy to confirm no large residual pneumothorax. Extubate the animal and allow it to recover from anesthesia. 16, [21] [22] [23] [24] . The use of a sustainable and reproducible swine MI model was a crucial step in order for these various research endeavors to obtain FDA Investigational New Drug (IND) approval.
Experimental intramyocardial stem cell injections design
The injection model is highly adaptable to the individual researcher, study design and expected endpoints. In addition to the ability to titrate scar size and ventricular impairment by altering occlusion time or location, interventions can be planned for time points from immediately after MI to days or weeks after MI. Interventions can easily be administered through catheterbased or direct surgical techniques, and both allow high levels of specificity in delivery locations and dosages within the myocardium. Although this protocol was developed for studying stem cell therapy in models of acute and chronic MI, this model can
Box 2 | Percutaneous transendocardial stem cell injections • tIMInG 45-70 min
See table 1 for a list of transendocardial injection devices and their characteristics. 1. Follow Steps 1-14 of the main PROCEDURE to prepare the animal and obtain CMR measurements. 2. Prepare the angiography table by placing a V-shaped trough tabletop adapter draped with a Bair hugger blanket and sand bags to position the animal properly and maintain euthermia. Secure the swine's caudal end in a dorsal recumbent position and restrain the hind limbs caudolaterally with slight flexion of the hip joint in order to properly palpate the femoral canal. Rotate the cranial end in a right lateral decubitus position with the front limbs secured. This positioning allows access to the left or right femoral vasculature and exposes the left lateral chest wall for surgical access to the heart via the left pleural cavity.  crItIcal step At a minimum, pulse oximetry and heart rate must be monitored during surgical preparation. Vital parameters such as pulse oximetry, heart rate, blood pressure, temperature and capnography should be monitored throughout the procedure to ensure proper anesthesia depth and swine health. 3. Obtain vascular access to the swine, as detailed in Step 17 of the main PROCEDURE. 4. Obtain preinjection pressure-volume measurements, as detailed in Steps 18-23 of the main PROCEDURE. 5. By using cardiac catheterization techniques under fluoroscopy guidance, advance a 0.038-inch J-tip guidewire through the arterial introducer into the LV retrograde across the aortic valve and advance a 6F pigtail catheter over the wire into the LV and retract the wire. 6. Under biplane fluoroscopy ( Fig. 8a ; 30° left anterior oblique and 30° right anterior oblique) obtain left ventriculograms. Pause the ventriculogram images at end diastole and trace endocardial borders on transparencies overlaying the on-screen images.  crItIcal step Do not move or adjust the swine, image intensifiers or C-arms once the ventriculogram is obtained, in order to ensure proper guiding of the injections. 7. Demarcate infarction and border zones on the transparencies on the basis of wall motion scoring and prior evaluation of post-MI CMR. Akinetic territories indicate infarct zones and hypokinetic territories identify border zones. 8. Advance a 0.038-inch J-tip exchange length guidewire through the pigtail into the LV, remove the pigtail over the wire, advance a steerable catheter (table 3) over the wire into the LV chamber and retract the wire. Advance a delivery catheter, if needed, through the steerable catheter into the LV. 9. Direct and advance the injection needle at the tip of the catheter to the targeted injection site under fluoroscopic guidance. Engage the delivery catheter into the myocardium at the targeted location (Fig. 10e) . Watch for needle stability during cardiac cycle to ensure proper engagement. Premature ventricular contractions also may indicate needle engagement with viable myocardium, but may not be present if engaged with scar tissue.  crItIcal step Myocardial wall thickness of the injection site, determined by at least one imaging modality, must be greater than nine millimeters. 10. Mark the catheter location on the LV tracings to record injection location and order. The tracing also provides a map of injections for later histopathological analysis if desired. 11. Administer the infusion of cells slowly to ensure safe delivery and minimize washout. After injection, leave the needle to dwell for a short time and then disengage it from the myocardium.  crItIcal step Proper mapping with CMR and left ventriculograms allows the investigator to plan and properly distribute the injections to the area(s) of interest, ensuring myocardial thickness of greater than 9 mm. Injection volumes should be planned not to exceed 0.5 ml per injection site and should be equally distributed throughout the targeted area(s). ? trouBlesHootInG 12. Repeat steps 9-11 for the desired number of injections (typically 10-15). 13. Close the incision site in layers. 14. Clean the surgical site in a sterile manner; place triple antibiotic ointment over the incision site and cover incision sites with sterile nonadherent pads and enclose with waterproof dressings. ? trouBlesHootInG  pause poInt Follow-up should be coordinated with the sample timelines shown in Figure 1 , or adjusted to the researchers' goals and anticipated timelines.
easily be adapted for other investigational studies, such as targeted pharmacological or gene therapies, and it provides an important step between in vivo small animal model research and the regulatory approval required for clinical trials [25] [26] [27] . Considering the reproducibility of this model, research is easily conducted and compared against existing published data or placebo animals (i.e., those treated under the same experimental conditions, but given an inert agent or delivery vehicle only).
Previous studies comparing intramyocardial injections through surgical or percutaneous methods have indicated that both methods have similar delivery capabilities, resulting in equivalent engraftment and cellular retention 18, 19, 26 . With this in mind, and with proper pre-IND coordination with the FDA, investigational studies using a surgical approach for product delivery can be translated to catheter-based delivery for clinical trials to reduce costs and data sharing requirements of some steerable catheter manufacturers.
Early preclinical stem cell studies used the 60-min infarct protocol, whereas the 120-min protocol has been used in previous chronic studies of ICM 6, 9 . These studies focused more on ejection fraction (EF) as an endpoint for efficacy of treatment and used a shorter duration of infarct than is currently used. As factors such as LV remodeling and scar reduction became more important endpoints of clinical studies, larger scar mass and greater LV dilation were needed for greater sensitivity in the results. To achieve this, the occlusion time was prolonged by 30 min in both the acute and chronic study protocols to create larger transmural infarcts. Atropine 1/120 grain, 100 ml (Webster Veterinary, cat. no. 07-806-9535, http://www.webstervet.com/) ! cautIon It is a skin and eye irritant and is toxic to the kidneys, the nervous system, the liver, the mucous membranes, the gastrointestinal tract and the cardiovascular system. Repeated or prolonged exposure can produce organ damage. Lidocaine (2% wt/vol), 50 ml (Webster Veterinary, cat. no. 07-865-8420, http://www.webstervet.com/) Heparin, 1,000 U ml (We recommend 3-4% isoflurane and 22-44 ml kg − 1 100% oxygen via simple nose cone and partial rebreather anesthesia circuit until the animal is intubated.)  crItIcal step At a minimum, pulse oximetry and heart rate must be monitored through anesthesia induction, maintenance and recovery. Induction and maintenance anesthesia regimens should be tailored to the preference and the proficiency of the team and to the animals used.
MaterIals

REAGENTS
3|
Clean the swine as needed, obtain i.v. access via the posterior auricular vein with a 22-gauge angiocatheter, and place a secure airway (endotracheal intubation with a 6.5-to 7.5-mm endotracheal tube is preferred for superior airway control and protection). Shave the surgical sites as necessary and move the animal from the preparation area to the procedure suite. ? trouBlesHootInG 4| Deliver ongoing maintenance anesthesia with 1-2% isoflurane and 0.5-1.5 liters per min oxygen through a mechanically ventilated closed-loop anesthesia machine (Fig. 2) .  crItIcal step The pulmonary tissues of swine are very fragile, so care should be taken to avoid pulmonary barotrauma. Standard tidal volumes for swine are 5-15 ml kg − 1 and peak inspiratory pressure should not exceed 18-20 cmH 2 O. cMr • tIMInG 45-60 min 5| Place the animal on the table head first and in the supine position. Place sand bags on either side of the animal in order to maintain the position.  crItIcal step Baseline noninvasive studies (CMR and late gadolinium enhancement (LGE)-CMR are recommended) of the heart should be performed to ensure normal cardiac structure and function before MI model creation.
6| By using the table coil elements posteriorly, place a dedicated phased array cardiac coil (body array coil) over the anterior part of the chest.
7|
Acquire multiplanar gradient echo scout images for optimal short axis, two-chamber, three-chamber and four-chamber long axis views of the heart.
8|
Obtain suspended respiration images with the use of a veterinary anesthesia delivery system. Obtain retrospective ECG-gated steady-state gradient echo-tagged (grid) and fast imaging steady-state free precession (TrueFisp) cine images in the short axis plane from the base of the LV to the apex of the heart. Field of view (280-300 mm) should be optimized according to the size of the animal. Take slice thickness at 4 mm for the TrueFisp images and 8 mm for the tagged images with a slice gap of 25% between slices. The tagged images require one average using a resolution matrix size of 224 × 167, whereas the TrueFisp images require two averages using a resolution matrix size of 256 2 (interpolated). The average acquisition time should be 15-20 s per slice. 
9|
Obtain TrueFisp cine images in the two-chamber, threechamber and four-chamber long axis view of the heart.
10|
Obtain perfusion and delayed enhancement images using a double-dose (0.2 mmol kg − 1
) contrast injection of Magnevist (gadopentetate dimeglumine). Inject contrast at a dose of 0.1 mmol kg − 1 , with the power injector (Medrad) set at 5 ml s − 1 , followed by 10 ml of saline flush for firstpass perfusion imaging. Deliver the second contrast dose of 0.1 mmol kg − 1 after the perfusion scan has been completed.
11|
Eight minutes after the first injection, obtain a TI scout (inversion time scout; for optimal inversion time for the delayed enhanced images) to null the myocardium.
12|
Obtain prospectively gated single-shot, phase-sensitive inversion-recovery (PSIR) delayed enhancement images in the short axis, two-chamber, three-chamber and four-chamber long axis view (Fig. 3a-c) .
13| Analyze images with offline software (Qmass) to determine end diastolic volume (EDV), end systolic volume (ESV), stroke volume, EF, LV mass and scar mass (Fig. 3d) .  pause poInt CMR images can be acquired up to 48 h before the procedure to allow time for offline analysis and review by the surgical team. The animal would then be recovered from anesthesia and Steps 1-4 would need to be followed again to prepare the animal for surgery. .  crItIcal step Antibiotic treatment is not a substitute for adhering to aseptic techniques for survival surgeries.
15| Prepare the angiography table by placing a V-shaped trough tabletop adapter draped with a Bair hugger blanket and sand bags to position the animal properly and maintain euthermia. Place the swine in a dorsal recumbent position and secure it using sand bags. Retract the front hooves and hold them posterior to facilitate access to the vasculature of the neck (Fig. 4) . Retract the rear hooves caudolaterally with slight flexion of the hip joint and restrain them in place to facilitate access to the femoral canal.  crItIcal step At a minimum, pulse oximetry and heart rate must be monitored during surgical preparation. Vital parameters such as pulse oximetry, heart rate, blood pressure, temperature and capnography should be monitored throughout the procedure to ensure proper anesthesia depth and swine health.
16|
Prepare and drape the surgical site(s) in an aseptic manner. (Fig. 5) . Dissect the s.c. tissue and the muscular plane between the cutaneous facii and cutaneous colli. Dissect the facial plane between the trachea and the sternomastoideus to palpate the carotid pulse and localize the carotid sheath (Fig. 5e) . Surgical dissection and cannulation of the right carotid artery provides the most direct, timely and reliable access to the left coronary sinus.  crItIcal step Care should be taken to avoid damaging the vagus nerve ( Fig. 5f ) and associated ganglion. Damage to the vagus nerve can lead to denervation of the recurrent laryngeal nerve and paralysis of the ipsilateral vocal cord with resulting loss of airway control. Damage to the cranial cervical sympathetic ganglion, overlaying the carotid artery, can lead to iatrogenic Horner syndrome. ? trouBlesHootInG (ii) Isolate the common carotid artery using blunt dissection in order to prevent damage to the vagus nerve that lies within the carotid sheath (Fig. 6) . Ligate arterial branches as needed to reduce blood loss and minimize risk of dissection of the artery. Gain vessel control with vessel loops or 0 surgical silk sutures (Fig. 6b) . (iii) Access the carotid artery using a Seldinger guidewire technique and secure a 7 or 9 French (F) introducer to the artery (Fig. 6c) . Bathe the artery in 2% lidocaine to dilate the vessel and facilitate access.  crItIcal step The smallest introducers that allow passage of all required catheters should be used in order to minimize trauma to all vessels that are not ligated upon removal of introducers. (iv) Bluntly dissect over the dorsal surface of the sternocephalic muscle to expose the EJ vein. Gain vessel control with 0 surgical silk sutures (Fig. 6d) . The EJ vein lies posterior to the planes of the sternocephalic and brachiocephalic muscles and anterior to the sternomastoideus.  crItIcal step The internal jugular vein is considerably smaller in caliber than the EJ vein, and therefore the EJ vein is isolated to obtain central venous access. (v) Access the EJ vein with the Seldinger technique and secure a 9F introducer in the vein (Fig. 6e) . Tie the proximal silk suture around the vein and introducer to prevent hemorrhage, and tie the distal silk suture to ligate the vein distal to the catheterization site.  crItIcal step All introducers must be secured to prevent uncontrolled hemorrhage.  crItIcal step The smallest introducers that allow passage of all required catheters should be used to minimize trauma to all vessels that are not ligated upon removal of introducers. All introducers placed must be secured to prevent uncontrolled hemorrhage.
Invasive pressure-volume measurements • tIMInG 30-45 min 18| Open recording software on a PC and connect the catheter (Fig. 7) . Perform catheter setup and pressure calibration according to the manufacturer's recommendations.
19|
Under fluoroscopy guidance, advance a 6F Judkins right catheter over the wire into the LV through the carotid/ femoral artery.
20|
Remove the wire while retaining the 6F Judkins right catheter in place. Advance a 5F straight conductance catheter (under fluoroscopy guidance) to the level of the LV. When the latter reaches the apex of the LV, start retracting the 6F Judkins right catheter over the conductance catheter to the level of the aorta, thereby exposing all of the conductance catheter electrodes (Fig. 8) .  crItIcal step Proximal segments having a figure eight loop indicate aortic measurements and must be excluded; alternatively, the catheter must be advanced further into the LV. Ensure that all the electrodes of the conductance catheter are inside the left ventricular chamber and that the tip of the catheter is facing the apex (Fig. 8c) . Ensure that the conductance catheter retains a stable and straight position approximately in the middle of the ventricular chamber, avoiding wall contact. If needed, adjust the position of the catheter to obtain rectangular-shaped pressure-volume loops (in diseased animals the shape may not be rectangular).
21|
After stabilization of the heart rhythm, stop mechanical ventilation and record baseline pressure-volume loops during steady state. When enough loops are recorded, stop recording and restore mechanical ventilation.
22|
Under fluoroscopy guidance, advance a 22F Fogarty balloon-occlusion catheter through the venous introducer into the inferior vena cava to the level of the diaphragm. When proper position is reached, stop mechanical ventilation and record pressure-volume loops during decreasing preload. The latter is achieved by inflating the balloon, leading to total inferior vena cava occlusion (Fig. 8d) . At this point, stop recording, restore ventilation and deflate the balloon. Repeat this process at least three times and average the indices.  crItIcal step In case of premature ventricular contractions during the recording of baseline or occlusion, exclude the corresponding loops (plus both pre-and post-incident loops). In case of multiple incidents, all the occlusion recordings should be discarded and repeated.
23| Perform offline analysis of the recorded data by calibrating the volume with the point and difference method using the EDV and stroke volume derived from the CMR studies (performed within 48 h of recording the pressure-volume loops, Fig. 7) . Start the dynamic state analysis at the point at which both systolic pressure and volume decline simultaneously and end at the point at which their decline reaches a plateau (Fig. 7d,f) .
? trouBlesHootInG 25| By using cardiac catheterization techniques under fluoroscopy guidance, advance a 0.038-inch J-tip exchange wire through the arterial introducer into the LV retrograde across the aortic valve.
26| Advance a 6F pigtail catheter over the wire into the LV and retract the wire. Obtain a left ventriculogram (30° left anterior oblique view with 20 ml of Omnipaque 350). Visualization of the coronary sinuses and left main coronary anatomy will allow faster placement of the PTCA balloon (Fig. 8b) .
27| Advance the J-tip wire through the pigtail and remove the catheter over the wire.
28|
For carotid access, advance a 6F Judkins right catheter over the wire to the level of the left coronary sinus and place at the coronary ostium without full engagement. For femoral access, use a 6F Judkins left catheter. Remove the J-tip wire from the catheter.  crItIcal step Placement is confirmed with a contrast angiogram of the left main coronary artery, ensuring reflux of contrast into the aorta (Fig. 8e) . Complete engagement of catheter with left coronary ostia can cause ventricular arrhythmias.
29| Advance a 0.014-inch guidewire into the LAD artery and advance a 3.0 × 20 mm (for Yorkshires) or 2.0 × 20 mm (for Göttingens) PTCA dilatation catheter over the wire until it is distal to the first diagonal branch of the LAD. ? trouBlesHootInG 30| Inflate PTCA balloon to the minimum pressure needed (3-9 atm) to ensure occlusion of the LAD distal to the balloon. Confirm occlusion with coronary angiogram while ensuring flow down the first diagonal (Fig. 8f) . Leave the PTCA balloon inflated, occluding all blood flow distal to the balloon for 90 min (for Yorkshires) or 150 min (for Göttingens). Scar size can be titrated to the desired MI size by varying occlusion times on the basis of the research design and the needs of the investigator. See also Figure 9 in the event of ECG changes.  crItIcal step Watch for ECG changes (Fig. 9) . Prepare to administer cardiopulmonary resuscitation if necessary. Have epinephrine, atropine, lidocaine and a defibrillator available. Early identification of dysrhythmias and rapid intervention markedly increases animal survival. (Boxes 1 and 2; Fig. 10) . If the study design calls for intervention days, weeks or months after MI, continue on to Step 33. The arteries will spasm with manipulation. If the artery is not properly exposed, the fascia surrounding it can cause the needle to miss the vessel lumen Bath the artery in 2% (wt/vol) lidocaine to dilate it. Be sure to expose the adventia by dissecting away the fascia covering the artery to ensure proper placement of the needle into the vessel lumen. Proper proximal control of the vessel with vessel loops will allow light tension to be placed on the artery to help the needlepoint pierce the vessel (Fig. 6c) 17A(i) Swine has ipsilateral eyelid ptosis, pupil miosis and facial anhydrosis after surgery
Cervical ganglia in the swine are located within the carotid sheath and can be easily damaged during carotid sheath surgery
Carefully dissect the carotid artery within the carotid sheath and be mindful of the cranial cervical sympathetic ganglion that are located within the carotid sheath 41 (continued) 
antIcIpateD results
The protocol described here provides a consistent and reliable model of MI along with techniques for performing intramyocardial injection of stem cells. Notably, the stem cell injection techniques reported can be easily adapted to other preclinical studies of targeted therapies after MI. The ischemia-reperfusion model of MI results in similar changes in cardiac structure and function to those seen in humans and closely replicates the clinical interventions for MI.
Fifty female Yorkshire swine weighing 35.0 ± 0.8 kg (weight-based inclusion criteria) and 18 Göttingen swine 45.8 ± 1.64 weeks old (age-based inclusion criteria) underwent the experimental protocol described to create our MI model. In the Yorkshire swine, the LV EF at baseline was 37.55 ± 0.75% (mean ± s.e.m.) and decreased to 29.07 ± 0.84% after MI, resulting in an average 22.24 ± 1.95% mean percent change decrease in EF (tables 2 and 3) . Similarly, the LV EF in Göttingen swine at baseline was 48.79 ± 1.12% and decreased to 32.42 ± 1.40%, resulting in a 33.6 ± 2.30 mean percent change decrease in EF. However, EF may not be the most reliable measure of cardiac performance because there are many hemodynamic factors that influence EF, such as contractility, preload, afterload and lusitropy 28 . Figure 11 shows characteristic changes in lusitropy as seen after MI creation by pressure-volume loop analysis. Because of this, remodeling has been suggested as a more sensitive noninvasive measurement than EF for endpoints in stem cell clinical trials and other advanced heart failure therapies 28, 29 . In addition to measuring EF, CMR is a robust modality for analyzing a variety of cardiac performance measurements, such as EDV, ESV, myocardial mass and scar size quantification. EDV before MI in Yorkshire swine was 72.10 ± 1.71 ml and increased to 96.17 ± 2.90 ml, resulting in an average increase of 34.66 ± 4.06% with a 2-week follow-up (table 2) . Similarly, EDV in Göttingen swine was 31.37 ± 1.75 ml at baseline and increased to 46.64 ± 1.95 ml, resulting in a 52.57 ± 6.93% increase with 3-month follow-up (table 3) . Marked LV dilation is evident in serial CMR follow-up studies, as seen from aneurysmal dilations forming in the apical third of the LV from post-MI remodeling (Figs. 3d and 12) . The scar mass and scar percentage of LV mass are also two useful parameters for demonstrating the reproducibility of the size of the infarct. In the Yorkshire swine, the scar mass is 13.4 ± 0.59 g and the scar percentage of LV mass was calculated as 17.2 ± 0.66%. In the Göttingen swine, the scar mass was 6.8 ± 0.31 g and the scar percentage of LV mass was calculated as 17.69 ± 0.65%. This model can then be used to inject stem cells using minimally invasive surgical techniques or catheter-based delivery systems. The protocol described should allow investigators to use a highly reproducible model with excellent animal survival. 
